Evaluation of rejection, infection, and malignancy outcomes in elderly liver transplant recipients receiving a similar level of immunosuppression compared to a younger group

In conclusion, our data suggests that elderly LTx recipients, when treated with a similar level of IS, had similar 1 year incidence of rejection, infection, malignancy, and patient survival as younger LTx recipients.PMID:34673200 | DOI:10.1016/j.trim.2021.101485

Source: Transplant Immunology - October 21, 2021 Category: Transplant Surgery Authors: Bassem Almalki Clare Kane Kathleen Cunningham Carly D'Agostino Antonia Novak Michelle Kapugi Daniela Ladner Jamie Schulte Source Type: research